Shanghai Shyndec Pharmaceutical's subsidiary obtained the registration certificate for Perindopril Indapamide tablets.

Shanghai Shyndec Pharmaceutical (600420.SH) announced that its wholly-owned subsidiary, China Pharmaceutical Group Industrial Co., Ltd. (referred to as China Pharmaceutical Industry), has received the "Drug Registration Certificate" issued by the National Medical Products Administration for the compound tablet of perindopril tert-butamine and indapamide. The compound tablet of perindopril tert-butamine and indapamide is used to treat primary hypertension in adults. This product is suitable for patients whose blood pressure cannot be completely controlled by taking perindopril alone.